• SENSEX 73,246.03
    -352.64 (--0.48%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
Back

Corporate News

SMS Pharmaceuticals to review Q2 financial results at board meeting November 4, 2026
28-Oct-2026, 12:49

SMS Pharmaceuticals Limited will hold a board meeting on Wednesday, November 4, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Ltd. The company has closed the trading window for its equity shares for designated persons, including directors, from October 1, 2026, until November 6, 2026, and will reopen it on November 7, 2026.